Published in Proc Soc Exp Biol Med on May 01, 1969
The kinetics of hematopoiesis in the light horse II. The hematological response to hemorrhagic anemia. Can J Comp Med (1975) 0.77
[Cost-benefit of the Schilling test using cobalt-57]. Rev Invest Clin (1992) 1.38
Red cell life span in iron deficiency anaemia. Br J Haematol (1967) 0.98
Nutritional deficiencey and anemia in Latin America: A collaborative study. Blood (1971) 0.96
Late-appearing Philadelphia chromosome in two patients with chronic myelogenous leukemia. Blood (1980) 0.91
Haemolysis and erythropoiesis. II. Reticulocytosis and rate of haemoglobin rise in haemolytic and deficiency anaemias. Br J Haematol (1969) 0.85
Red cell indices in normal adults residing at altitude from sea level to 2670 meters. Am J Hematol (1980) 0.84
Androstane therapy of aplastic anaemia. Acta Haematol (1972) 0.83
Marrow radioiron kinetics. Haematologia (Budap) (1973) 0.83
Hemolysis and erythropoiesis. VI. A comparative study of the utilization of hemoglobin iron and transferrin iron by the erythropoietic tissue. Blood (1970) 0.81
[Utility of the copper/zinc ratio in patients with lymphoma or acute or chronic leukemias]. Rev Invest Clin (1996) 0.79
The erythropoietic effects of anabolic steroids. Proc Soc Exp Biol Med (1967) 0.78
Hemolysis and erythropoiesis. 3. The effect of hemolysis and hemolysates on erythropoiesis. Ann N Y Acad Sci (1968) 0.76
Recombinant interferon alfa-2B in refractory idiopathic immune thrombocytopenia. Blood (1990) 0.75
Hemolysis and erythropoiesis. IV. Effect of hemolysates on the erythropoiesis of normal, starved, and polycythemic rats. J Lab Clin Med (1968) 0.75
[Anemia in pregnancy. I. Study of 143 pregnant women of Humantla, Tlaxcala]. Gac Med Mex (1967) 0.75
[Therapy of hematologic diseases using androgens]. Munch Med Wochenschr (1971) 0.75
[Transfusion pathology. Experience in Mexico. 8. Conclusions]. Gac Med Mex (1971) 0.75
[Transfusion pathology. Experience in Mexico. I. Introduction]. Gac Med Mex (1971) 0.75
Favorable effect of anabolic steroids in a case of pure red cell anemia. Acta Cient Venez (1968) 0.75
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency]. Gac Med Mex (1976) 0.75
[Strategies to promote clinical research]. Gac Med Mex (1978) 0.75
Molecular differentiation of two different translocations producing two apparent Ph chromosomes in a patient with CML. Cancer Genet Cytogenet (1991) 0.75
[Comparison between the nutritional state of the mother and the newborn infant]. Gac Med Mex (1969) 0.75
[Partial trisomy 1q in the bone marrow of a patient with polycythemia vera]. Rev Invest Clin (1988) 0.75
[Osseous metastasis of uncommon localization in gastric carcinoma]. Rev Invest Clin (1971) 0.75
[Lymphoma and salmonellosis]. Rev Invest Clin (1972) 0.75
Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate. Arch Med Res (1993) 0.75
Simple modification to improve the reliability of red cell volume estimation. Tech Bull Regist Med Technol (1968) 0.75
[Disseminated intravascular coagulation. Report of 3 cases]. Sangre (Barc) (1971) 0.75
[Androstanes in clinical hematology]. Rev Clin Esp (1971) 0.75
[The "clinical expedient" and its importance in medical care and education. IV. The "clinical expedient" as a research tool]. Gac Med Mex (1980) 0.75
[Nutritional anemia. I. Red series values in healthy adult males living at 2,240 meters above sea level]. Rev Invest Clin (1971) 0.75
Patient with chronic myelogenous leukemia and late appearing Philadelphia chromosome. Cancer Genet Cytogenet (1982) 0.75
Nutritional anemia. VI. Fetal hepatic storage of metabolites in the second half of pregnancy. J Pediatr (1977) 0.75
[The capital sins of the physician]. Gac Med Mex (1978) 0.75
[Blood transfusion]. Gac Med Mex (1971) 0.75
Simple modification to improve the reliability of red cell volume estimation. Am J Clin Pathol (1968) 0.75
[Lymphoma and salmonellosis]. Rev Invest Clin (1971) 0.75
[Hepatic changes in patients under anabolic therapy]. Rev Invest Clin (1971) 0.75
[Iron deficiency in pregnancy and childhood]. Bol Oficina Sanit Panam (1971) 0.75
Erythrocytic production in anemias. I. The use of the survival curve for estimating production in the nonsteady state. J Nucl Med (1972) 0.75